Vor Biopharma VOR Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's change in AP?
- Vor Biopharma (VOR) reported change in AP of -$9.1M in Q1 2026.
- How has Vor Biopharma's change in AP changed year-over-year?
- Vor Biopharma's change in AP decreased by 562.8% year-over-year, from -$1.37M to -$9.1M.
- What is the long-term trend for Vor Biopharma's change in AP?
- Over 3 years (2021 to 2025), Vor Biopharma's change in AP has grown at a 200.0% compound annual growth rate (CAGR), from $405K to $10.93M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.